* Allscripts Healthcare Solutions Inc MDRX.OQ MDRX.O is
expected to show a fall in quarterly revenue when it reports
results on November 3.
* The Chicago Illinois-based company is expected to report
a
58.6% decrease in revenue to $152.805 million from $369.2
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Allscripts
Healthcare
Solutions Inc is for earnings of 19 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Allscripts
Healthcare Solutions Inc is $22, above its last closing price
of $14.67.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.15 0.15 0.18 Beat 18.9
Mar. 31 2022 0.21 0.21 0.13 Missed -38.6
Dec. 31 2021 0.35 0.32 0.79 Beat 145.2
Sep. 30 2021 0.18 0.18 0.27 Beat 47.3
Jun. 0.18 0.17 0.23 Beat 31.9
30 2021
Mar. 31 2021 0.15 0.15 0.19 Beat 23.5
Dec. 31 2020 0.22 0.21 0.29 Beat 36.6
Sep. 30 2020 0.19 0.19 0.20 Beat 5.6
This summary was machine generated November 2 at 02:01 GMT. All
figures in US dollars unless otherwise stated